Patent · US Active

Spliceostatin analogs and methods for their preparation

US9504669B2 · kind B2 · utility

3Cited by
9References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2015
Grant dateNov 29, 2016
Priority date
Expiry dateAug 5, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to novel cytotoxic spliceostatin analogs and derivatives, to antibody drug conjugates thereof, and to methods for using the same to treat medical conditions including cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.